Corporate ActionJun 15, 2026, 04:22 PM
CareDx Stockholders Approve 1.6M Share Increase for Equity Plan
AI Summary
CareDx, Inc. held its 2026 Annual Meeting of Stockholders where shareholders approved an amendment to the 2024 Equity Incentive Plan, increasing the shares reserved by 1,600,000. Stockholders also elected five directors, ratified Deloitte & Touche LLP as the independent auditor for 2026, and approved executive compensation on an advisory basis. They also advised a one-year frequency for future advisory votes on executive compensation.
Key Highlights
- Stockholders approved an amendment to the 2024 Equity Incentive Plan.
- The Plan Amendment increases available shares reserved by 1,600,000, approximately 3.1% of common shares outstanding.
- Five directors (Fred E. Cohen, R. Bryan Riggsbee, Suresh Gunasekaran, Michael D. Goldberg, John W. Hanna) were elected for one-year terms.
- Deloitte & Touche LLP was ratified as the independent registered public accounting firm for fiscal year 2026.
- Stockholders approved, on a non-binding advisory basis, the compensation of named executive officers.
- Stockholders advised a "one year" frequency for future advisory votes on executive compensation.
Price Impact
More from CDNA
Quarterly ResultApr 28, 4:18 PM
CDNA Q1 Revenue +39% to $117.7M; Net Income $2.8M vs Loss
AcquisitionsApr 28, 4:12 PM
CDNA to Acquire Naveris for $160M; Q1 Revenue +39% to $118M; Raises FY26 Guidance
AGM/EGMApr 27, 4:14 PM
CDNA Sets 2026 Annual Meeting for June 11; Key Proposals Include Director Election, Equity Plan Amendment